Actively Recruiting
Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia
Led by Wonju Severance Christian Hospital · Updated on 2025-09-26
588
Participants Needed
3
Research Sites
96 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
HELP-A study is a single-center, randomized, controlled trial. A total of 588 patients enrolled during the 2 years of enrollment period and followed for 1 month of follow-up period. This study aims to compare diagnostic yield between continuous ECG Patch and intermittent handheld ECG in patients with arrhythmia symptoms.
CONDITIONS
Official Title
Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who have arrhythmia symptoms but are not diagnosed on a 12-lead electrocardiogram and require additional tests.
- Patients who can use a smartphone
You will not qualify if you...
- Patients who have cardiac implantable electronic devices(CIEDs)
- Patients who can't use handheld ECG
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Chonnam National University Hospital
Gwangju, Dong-gu Jaebongro 42, South Korea, 61469
Actively Recruiting
2
Wonju Severance Christian Hospital
Wŏnju, Gangwon-do, South Korea, 26426
Actively Recruiting
3
Hallym University Dongtan Sacred Heart Hospital
Gyeonggi-do, Hwaseong-si Keunjaebong-gil 7, South Korea, 18450
Actively Recruiting
Research Team
Y
Young Jun Park, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here